Cleared Traditional

K243264 - DHF 0.2 Hemoconcentrator (DHF 02)

Also marketed or referenced as:
DHF 0.6 Hemoconcentrator (DHF 06) SH 14 Hemoconcentrator (SH 14)

K243264 is an FDA 510(k) clearance for DHF 0.2 Hemoconcentrator (DHF 02), manufactured by Sorin Group Italia S.R.L.. The device is a Class 2 Gastroenterology & Urology device with product code KDI cleared through the Traditional 510(k) pathway after a 192-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 2025
Decision
192d
Days
Class 2
Risk

K243264 is an FDA 510(k) clearance for the DHF 0.2 Hemoconcentrator (DHF 02). Classified as Dialyzer, High Permeability With Or Without Sealed Dialysate System (product code KDI), Class II - Special Controls.

Submitted by Sorin Group Italia S.R.L. (Mirandola ( Modena), IT). The FDA issued a Cleared decision on April 25, 2025 after a review of 192 days - an extended review cycle.

This device falls under the Gastroenterology & Urology FDA review panel, regulated under 21 CFR 876.5860 - the FDA gastroenterology and urology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Gastroenterology & Urology review framework, consistent with the majority of Class II 510(k) submissions.

View all Sorin Group Italia S.R.L. devices

FDA 510(k) Submission Details - K243264

510(k) Number K243264 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 15, 2024
Decision Date April 25, 2025
Days to Decision 192 days
Submission Type Traditional
Review Panel Gastroenterology & Urology (GU)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
61d slower than avg
Panel avg: 131d · This submission: 192d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

KDI Device Classification - Class 2, Special Controls

Product Code KDI Dialyzer, High Permeability With Or Without Sealed Dialysate System
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 876.5860
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Gastroenterology & Urology devices follow this clearance model.

Regulatory Peers - KDI Dialyzer, High Permeability With Or Without Sealed Dialysate System

All 294
Devices cleared under the same product code (KDI) and FDA review panel - the closest regulatory comparables to K243264.
2008T HD SYS. CDX BLUESTAR (191124)
K243237 · Fresenius Medical Care Renal Therapies Group, LLC · Jun 2025
5008X Hemodialysis System
K243505 · Fresenius Medical Care Renal Therapies Group, LLC · May 2025
DBB-06 PRO Hemodialysis Delivery System (DBB-06 PRO)
K242155 · NIKKISO CO., LTD. · May 2025
FX CorAL 40 (F00009214)
K242053 · Fresenius Medical Care Renal Therapies Group, LLC · Mar 2025
FX CorAL 60 (F00012969)
K243874 · Fresenius Medical Care Renal Therapies Group, LLC · Feb 2025
Moda-flx Hemodialysis System and Cartridge
K233798 · Diality, Inc. · Aug 2024